Australians living with asthma and other chronic respiratory conditions are facing growing difficulties accessing Ventolin Nebules, as a nationwide shortage continues to affect pharmacies during one of the busiest periods for respiratory illnesses.
Ventolin Nebules contain salbutamol, a fast-acting medication delivered through a nebuliser to help open the airways during asthma attacks and severe breathing difficulties. The treatment is commonly used by children, elderly patients and people experiencing acute asthma episodes or respiratory illnesses such as respiratory syncytial virus (RSV).
Pharmacists across Australia have reported increasing difficulty obtaining supplies of the medication, forcing many patients to visit multiple pharmacies before finding available stock. Some healthcare providers have also been required to consider alternative treatment options where appropriate.
According to pharmacists, the shortage has been driven by a combination of manufacturing supply constraints and unusually high seasonal demand. Australia has experienced a significant increase in respiratory infections this winter, including RSV, influenza and COVID-19, leading to greater demand for asthma medications and emergency respiratory treatments.
The Therapeutic Goods Administration (TGA) has listed Ventolin Nebules as being in short supply and is working with the manufacturer and healthcare providers to manage supplies while new stock is distributed. Authorities expect intermittent shortages to continue until manufacturing and supply chains return to normal.
Health professionals are encouraging patients not to stockpile the medication, warning that unnecessary purchasing can worsen shortages for people who urgently need treatment. Pharmacists say most patients who use Ventolin Nebules regularly should continue speaking with their doctor or pharmacist before making any changes to their treatment plan.
For many patients, Ventolin inhalers remain available and may be suitable as an alternative depending on individual medical circumstances. However, healthcare professionals stress that patients should only change medications after receiving medical advice, as nebulised therapy may still be necessary for some people, particularly young children or those experiencing severe asthma attacks.
The National Asthma Council Australia has reminded people with asthma to ensure they have an up-to-date asthma action plan and to monitor symptoms closely during the winter virus season. Early treatment of worsening symptoms and regular use of prescribed preventer medications can help reduce the risk of serious asthma attacks.
Medical experts also recommend practising good hygiene, staying home when unwell and keeping vaccinations up to date to reduce the spread of respiratory viruses that can trigger asthma flare-ups.
Pharmacy groups are continuing to work with suppliers to distribute available stock as fairly as possible across Australia. In some areas, pharmacists have implemented limits on the number of packs supplied to each customer to ensure medicines remain available for patients with immediate clinical needs.
The TGA continues to monitor the shortage and publish updates on expected supply dates. Patients who are unable to obtain Ventolin Nebules are encouraged to speak with their pharmacist or healthcare provider about suitable alternatives and to seek urgent medical attention if they experience severe breathing difficulties or symptoms that do not improve with treatment.
Authorities expect supply to gradually improve as additional shipments arrive, but pharmacists say demand is likely to remain high while winter respiratory illnesses continue circulating throughout Australia.
